| Mosaic ImmunoEngineering Inc. (PTSC) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2021-Mar-31 | 2020-Aug-31 | 2020-May-31 | 2020-Feb-29 | 2019-Nov-30 | 2019-Aug-31 | 2019-May-31 | 2019-Feb-28 | 2018-Nov-30 | 2018-Aug-31 | 2018-May-31 | 2018-Feb-28 | 2017-Nov-30 | 2017-Aug-31 | 2017-May-31 | 2017-Feb-28 | 2016-Nov-30 | 2016-Aug-31 | 2016-May-31 | 2016-Feb-29 | 2015-Nov-30 | 2015-Aug-31 | 2015-May-31 | 2015-Feb-28 | 2014-Nov-30 | 2014-Aug-31 | 2014-May-31 | |||||||||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q4-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | |||||||||||||
| Operating Cash Flow | (28,139$) | (21,822$) | (32,347$) | (29,089$) | (20,717$) | (12,998$) | (116,305$) | (91,139$) | (170,375$) | (55,156$) | 500$ | (214,120$) | (275,711$) | (320,022$) | (229,119$) | (106,985$) | (164,337$) | (260,325$) | (209,352$) | (186,425$) | (255,471$) | (228,922$) | (386,066$) | (230,987$) | (274,585$) | (419,194$) | (360,081$) | (358,974$) | (307,806$) | (551,423$) | (332,607$) | (212,549$) | (332,174$) | (467,277$) | (308,439$) | ||||||||||||||
| Investing Cash Flow | 27,637$ | 605,215$ | 0$ | 0$ | 500,000$ | 250,000$ | (750,000$) | 177,246$ | 0$ | 0$ | 700,000$ | 1,548,535$ | 450,000$ | (500,000$) | (450,000$) | (50,000$) | 1,383,600$ | 247,297$ | 500$ | 0$ | 42,000$ | 16,000$ | (392,400$) | (499,740$) | 200,376$ | (700,000$) | |||||||||||||||||||||||
| Purchases of Property and Equipment | 0$ | 0$ | 1,465$ | 0$ | 0$ | 0$ | 0$ | 0$ | 2,703$ | 0$ | 0$ | 0$ | 0$ | 477$ | 0$ | 540$ | 702$ | 0$ | |||||||||||||||||||||||||||||||
| Financing Cash Flow | 130,000$ | 15,000$ | 63$ | 0$ | (137,345$) | ||||||||||||||||||||||||||||||||||||||||||||
| End Cash Position | 3,622$ | 31,761$ | 53,583$ | 85,930$ | 115,019$ | 5,736$ | 3,734$ | 65,039$ | 156,178$ | 220,645$ | 226,142$ | 210,000$ | 373,378$ | 500$ | 748,829$ | 962,949$ | 738,660$ | 787,086$ | 1,766,161$ | 1,873,174$ | 2,037,537$ | 2,297,890$ | 1,807,277$ | 445,194$ | 250,692$ | 979,641$ | 1,815,707$ | 2,096,694$ | 987,679$ | 1,159,576$ | 1,519,157$ | 1,878,131$ | 2,143,937$ | 2,679,360$ | 3,012,444$ | 3,617,393$ | 4,449,307$ | 4,716,208$ | |||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (28,139$) | (21,822$) | (32,347$) | (29,089$) | (20,717$) | (12,998$) | (116,305$) | (91,139$) | (170,375$) | (55,156$) | 500$ | (214,120$) | (275,711$) | (320,022$) | (229,119$) | (106,985$) | (164,337$) | (260,325$) | (209,352$) | (187,890$) | (255,471$) | (228,922$) | (386,066$) | (230,987$) | (274,585$) | (421,897$) | (360,081$) | (358,974$) | (307,806$) | (551,423$) | (333,084$) | (212,549$) | (332,714$) | (467,979$) | (308,439$) | ||||||||||||||